🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 02/12/1992 | 0,1193 USD |
| 31/08/1992 | 0,1193 USD |
| 02/06/1992 | 0,1097 USD |
| 02/03/1992 | 0,1097 USD |
| 02/12/1991 | 0,1002 USD |
| 30/08/1991 | 0,1002 USD |
| 03/06/1991 | 0,0891 USD |
| 04/03/1991 | 0,0891 USD |
| 03/12/1990 | 0,0891 USD |
| 28/08/1990 | 0,0891 USD |
| 29/05/1990 | 0,0716 USD |
| 05/03/1990 | 0,0716 USD |
| 04/12/1989 | 0,0716 USD |
| 29/08/1989 | 0,0716 USD |
| 30/05/1989 | 0,0652 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 31/07/1990 | 14,29 | 14,33 | 14,03 | 14,17 | -0,42% | 2,09% | 4.491.518 |
| 30/07/1990 | 13,94 | 14,23 | 13,92 | 14,23 | +1,42% | 2,28% | 3.693.571 |
| 27/07/1990 | 14,27 | 14,29 | 14,01 | 14,03 | -1,81% | 1,95% | 2.737.166 |
| 26/07/1990 | 14,35 | 14,47 | 14,21 | 14,29 | +0,98% | 1,80% | 4.912.186 |
| 25/07/1990 | 14,01 | 14,21 | 13,99 | 14,15 | +0,56% | 1,56% | 3.425.074 |
| 24/07/1990 | 14,09 | 14,09 | 13,72 | 14,07 | +0,00% | 2,68% | 5.546.016 |
| 23/07/1990 | 14,31 | 14,31 | 13,48 | 14,07 | -1,67% | 5,83% | 9.282.346 |
| 20/07/1990 | 14,29 | 14,49 | 14,29 | 14,31 | -0,28% | 1,39% | 8.474.966 |
| 19/07/1990 | 14,29 | 14,35 | 14,17 | 14,35 | +0,14% | 1,25% | 6.017.616 |
| 18/07/1990 | 14,31 | 14,47 | 14,25 | 14,33 | +0,14% | 1,53% | 5.479.363 |
| 17/07/1990 | 14,25 | 14,31 | 14,19 | 14,31 | +0,28% | 0,84% | 3.507.446 |
| 16/07/1990 | 14,17 | 14,31 | 14,11 | 14,27 | +0,98% | 1,40% | 4.588.982 |
| 13/07/1990 | 14,05 | 14,23 | 13,99 | 14,13 | +0,71% | 1,70% | 4.437.442 |
| 12/07/1990 | 13,96 | 14,05 | 13,90 | 14,03 | +0,00% | 1,14% | 4.948.656 |
| 11/07/1990 | 13,82 | 14,03 | 13,76 | 14,03 | +2,17% | 2,01% | 3.359.050 |
| 10/07/1990 | 13,76 | 13,88 | 13,72 | 13,74 | -0,14% | 1,16% | 3.262.843 |
| 09/07/1990 | 13,74 | 13,76 | 13,66 | 13,76 | +0,00% | 0,72% | 3.166.008 |
| 06/07/1990 | 13,74 | 13,86 | 13,70 | 13,76 | +0,44% | 1,16% | 3.169.152 |
| 05/07/1990 | 13,88 | 13,92 | 13,64 | 13,70 | -1,71% | 2,01% | 3.552.720 |
| 03/07/1990 | 13,84 | 13,99 | 13,84 | 13,94 | +0,72% | 1,15% | 3.486.067 |
| 02/07/1990 | 13,78 | 13,88 | 13,70 | 13,84 | +0,29% | 1,30% | 2.481.245 |
| 29/06/1990 | 13,72 | 13,88 | 13,72 | 13,80 | +0,73% | 1,16% | 4.827.926 |
| 28/06/1990 | 13,48 | 13,72 | 13,46 | 13,70 | +2,23% | 1,92% | 5.320.277 |
| 27/06/1990 | 13,18 | 13,46 | 13,18 | 13,40 | +1,66% | 2,11% | 3.579.758 |
| 26/06/1990 | 13,12 | 13,22 | 13,10 | 13,18 | +0,76% | 0,91% | 2.994.974 |
| 25/06/1990 | 13,08 | 13,16 | 13,00 | 13,08 | +0,61% | 1,22% | 3.124.507 |
| 22/06/1990 | 13,28 | 13,46 | 13,00 | 13,00 | -2,24% | 3,44% | 6.565.930 |
| 21/06/1990 | 13,12 | 13,30 | 13,10 | 13,30 | +1,67% | 1,51% | 4.686.446 |
| 20/06/1990 | 13,02 | 13,08 | 12,94 | 13,08 | +0,92% | 1,07% | 3.645.154 |
| 19/06/1990 | 12,96 | 13,00 | 12,88 | 12,96 | +0,00% | 0,92% | 3.072.946 |